Pfizer vaccine data meets expectations for emergency use approval: US FDA
The US Food and Drug Administration (FDA) has said that Pfizer-BioNTech COVID-19 vaccine's efficacy and safety data met its expectations for emergency use authorisation. The USFDA will meet on Thursday to make a formal decision on approving the vaccine for emergency use in the country. Last week, the UK became the first country to approve the vaccine for widespread use.